CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 2 out of 5 Outperform 5Y $51.37 $43.63 (+3.00%) -15.07% +7.35% -22.43
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $0.27 (+5.17%) -84.09% +7.35% -91.44
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.59 (+5.36%) -69.59% +7.35% -76.94
17/03/2014 GDXJ.US 4 out of 5 Outperform 5Y $44.00 $20.48 (+5.03%) -53.45% +7.35% -60.81
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $33.73 $24.57 (+4.83%) -27.16% +7.35% -34.52
17/03/2014 ANVGQ.US 2 out of 5 Outperform 5Y $6.37 $0.06 (+7.22%) -99.04% +7.35% -106.40
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.43 $13.96 (+2.05%) -49.11% +7.35% -56.47
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $518.01 (-0.07%) +188.26% +45.07% -143.19
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $1.68 (+10.53%) -72.95% +33.08% -106.02
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $2.57 (+6.20%) -42.51% +31.30% -73.81
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $15.74 $6.73 (+7.00%) -57.25% +31.30% -88.56
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $2.54 (+2.42%) -20.62% +32.52% -53.14
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.30 (-1.62%) -93.38% +32.52% -125.90
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $6.53 (+7.22%) -45.99% +32.54% -78.53
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $12.21 $2.41 (+4.78%) -80.26% +32.54% -112.80
24/01/2013 SGSVF.US 3 out of 5 Outperform 5Y $2.51 $0.26 (+4.37%) -89.82% +33.58% -123.40
23/01/2013 NRT.US 2 out of 5 Outperform 1Y $19.52 $11.24 (-0.27%) -42.43% +33.60% -76.03
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $8.91 (+3.60%) +70.69% +33.60% +37.09
23/01/2013 POT.US 4 out of 5 Outperform 5Y $37.60 $25.95 (+0.70%) -30.98% +33.60% -64.58
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $1.71 (+8.92%) -83.84% +35.64% -119.48
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.